These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 7350870)

  • 21. Penicillamine in rheumatoid arthritis. A problem of toxicity.
    Taylor HG; Samanta A
    Drug Saf; 1992; 7(1):46-53. PubMed ID: 1536698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The relationship between D-penicillamine--induced proteinuria and prior gold nephropathy.
    Billingsley LM; Stevens MB
    Johns Hopkins Med J; 1981 Feb; 148(2):64-7. PubMed ID: 7206401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selected adverse reactions of D-penicillamine.
    Stein HB; Chalmers A; Schroeder ML; Dillon A
    Clin Invest Med; 1984; 7(1):73-6. PubMed ID: 6723128
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Penicillamine: its use in rheumatoid arthritis].
    Colombo B; Gerloni V
    Recenti Prog Med; 1979 Feb; 66(2):136-87. PubMed ID: 155862
    [No Abstract]   [Full Text] [Related]  

  • 25. The side effects of penicillamine therapy in rheumatoid arthritis.
    Huskisson EC
    J Rheumatol Suppl; 1981; 7():146-8. PubMed ID: 6939876
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proteinuria in D-penicillamine-treated rheumatoid arthritis.
    Crawhall JC
    J Rheumatol Suppl; 1981; 7():161-3. PubMed ID: 6939879
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toxicity to D-penicillamine in rheumatoid arthritis.
    Magnus JH; Gran JT; Mikkelsen K; Nygaard H; Brath HK
    Scand J Rheumatol; 1987; 16(6):441-4. PubMed ID: 2962277
    [No Abstract]   [Full Text] [Related]  

  • 28. Resumption of treatment with penicillamine after proteinuria.
    Hill H; Hill A; Davison AM
    Ann Rheum Dis; 1979 Jun; 38(3):229-31. PubMed ID: 485579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intermittent treatment with D-penicillamine is effective in lower doses and with fewer adverse effects in patients with rheumatoid arthritis.
    Hakoda M; Taniguchi A; Kamatani N; Akahoshi T; Kashiwazaki S
    J Rheumatol; 1994 Sep; 21(9):1637-41. PubMed ID: 7799341
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Editorial: D-penicillamine in rheumatoid arthritis.
    Lancet; 1975 May; 1(7916):1123-5. PubMed ID: 49477
    [No Abstract]   [Full Text] [Related]  

  • 31. Penicillamine in rheumatoid arthritis: adverse effects.
    Hill HF
    Scand J Rheumatol Suppl; 1979; (28):94-9. PubMed ID: 156393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [D-penicillamine therapy in rheumatoid arthritis: adverse reactions with 2 different administration regimens].
    Fernández Dapica P; Peña J; Merino J; Casanueva B; Morillas L; Mateo I; Rodríguez-Valverde V; Gómez-Reino J
    Med Clin (Barc); 1984 Jun; 83(5):184-7. PubMed ID: 6482577
    [No Abstract]   [Full Text] [Related]  

  • 33. Penicillamine compared to previous chrysotherapy in rheumatoid arthritis.
    Stein HB; Ruedy J; Atkins CJ; Offer RC
    J Rheumatol; 1983 Apr; 10(2):319-22. PubMed ID: 6864688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Penicillamine in rheumatoid disease: a long-term study.
    Day AT; Golding JR; Lee PN; Butterworth AD
    Br Med J; 1974 Feb; 1(5900):180-3. PubMed ID: 4590670
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthetic D(-)penicillamine in rheumatoid arthritis. Double-blind controlled study of a high and low dosage regimen.
    Dixon AJ; Davies J; Dormandy TL; Hamilton EB; Holt PJ; Mason RM; Thompson M; Weber JC; Zutshi DW
    Ann Rheum Dis; 1975 Oct; 34(5):416-21. PubMed ID: 769707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic markers in rheumatoid arthritis relationship to toxicity from D-penicillamine.
    Stockman A; Zilko PJ; Major GA; Tait BD; Property DN; Mathews JD; Hannah MC; McCluskey J; Muirden KD
    J Rheumatol; 1986 Apr; 13(2):269-73. PubMed ID: 3459889
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A study of the combined effect of ACTH(gel) and D-penicillamine on the functional disability of patients with rheumatoid disease.
    Donnelly P; Cooke D
    J Rheumatol; 1982; 9(6):867-72. PubMed ID: 6298415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The basal therapy of rheumatoid arthritis with d-penicillamine (author's transl)].
    Waskönig FW; Meyer W
    Munch Med Wochenschr; 1973 Nov; 115(45):2047-50. PubMed ID: 4801138
    [No Abstract]   [Full Text] [Related]  

  • 39. Auranofin or D-penicillamine in the treatment of rheumatoid arthritis.
    Hochberg MC
    Ann Intern Med; 1986 Oct; 105(4):528-35. PubMed ID: 3092712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toxicity of D-penicillamine in rheumatoid arthritis.
    O'Brien WM
    Ann Intern Med; 1980 Jan; 92(1):120-2. PubMed ID: 7350856
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.